We use cookies to ensure that our site works correctly and provides you with the best experience. If you continue using our site without changing your browser settings, we'll assume that you agree to our use of cookies. Find out more about the cookies we use and how to manage them by reading our cookies policy. Hide

Current Issue

19th February 2020
Selected Chemistry & Industry magazine issue

Select an Issue


C&I e-books

C&I e-books

C&I apps

iOS App
Android App


Business digest


Global life science company Abcam, based in Cambridge, UK, has acquired the gene-editing platform and oncology product portfolio of US biotechnology company Applied StemCell. The transaction expands Abcam’s position in the gene-editing market. Financial details were not disclosed.

Read more

Cutting corners?

Alexios Chronis, 19/02/2020

Alexios Chronis, from CSols, examines if it is possible to cut corners when adopting a new informatics implementation project

Read more